Literature DB >> 28238045

Estimation of the cumulative incidence function under multiple dependent and independent censoring mechanisms.

Judith J Lok1, Shu Yang2, Brian Sharkey3, Michael D Hughes4.   

Abstract

Competing risks occur in a time-to-event analysis in which a patient can experience one of several types of events. Traditional methods for handling competing risks data presuppose one censoring process, which is assumed to be independent. In a controlled clinical trial, censoring can occur for several reasons: some independent, others dependent. We propose an estimator of the cumulative incidence function in the presence of both independent and dependent censoring mechanisms. We rely on semi-parametric theory to derive an augmented inverse probability of censoring weighted (AIPCW) estimator. We demonstrate the efficiency gained when using the AIPCW estimator compared to a non-augmented estimator via simulations. We then apply our method to evaluate the safety and efficacy of three anti-HIV regimens in a randomized trial conducted by the AIDS Clinical Trial Group, ACTG A5095.

Entities:  

Keywords:  Competing risks; Cumulative incidence function; Dependent censoring; Inverse probability weighting

Mesh:

Year:  2017        PMID: 28238045      PMCID: PMC5572121          DOI: 10.1007/s10985-017-9393-4

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  15 in total

1.  Regression modeling of competing crude failure probabilities.

Authors:  J P Fine
Journal:  Biostatistics       Date:  2001-03       Impact factor: 5.899

2.  Analysis of quality-of-life adjusted failure time data in the presence of competing, possibly informative, censoring mechanisms.

Authors:  Andrea Rotnitzky; Andrea Bergesio; Andres Farall
Journal:  Lifetime Data Anal       Date:  2008-06-25       Impact factor: 1.588

3.  Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment.

Authors:  J P Ioannidis; R Bassett; M D Hughes; P A Volberding; H S Sacks; J Lau
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1997-09-01

4.  Predictors identified for losses to follow-up among HIV-seropositive patients.

Authors:  Emilie Lanoy; Murielle Mary-Krause; Pierre Tattevin; Rosemary Dray-Spira; Claudine Duvivier; Patricia Fischer; Yolande Obadia; France Lert; Dominique Costagliola
Journal:  J Clin Epidemiol       Date:  2006-05-30       Impact factor: 6.437

5.  Factors associated with the failure of HIV-positive persons to return for scheduled medical visits.

Authors:  Claudio Arici; Diego Ripamonti; Franco Maggiolo; Marco Rizzi; Maria Grazia Finazzi; Patrizio Pezzotti; Fredy Suter
Journal:  HIV Clin Trials       Date:  2002 Jan-Feb

6.  Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Christina Lalama; Bruce R Schackman; William A Meyer; Edward P Acosta; Jeffrey Schouten; Kathleen E Squires; Christopher D Pilcher; Robert L Murphy; Susan L Koletar; Margrit Carlson; Richard C Reichman; Barbara Bastow; Karin L Klingman; Daniel R Kuritzkes
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

7.  Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.

Authors:  Roy M Gulick; Heather J Ribaudo; Cecilia M Shikuma; Stephanie Lustgarten; Kathleen E Squires; William A Meyer; Edward P Acosta; Bruce R Schackman; Christopher D Pilcher; Robert L Murphy; William E Maher; Mallory D Witt; Richard C Reichman; Sally Snyder; Karin L Klingman; Daniel R Kuritzkes
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

8.  Factors associated with early study discontinuation in AACTG studies, DACS 200.

Authors:  Janet W Andersen; Robert Fass; Charles van der Horst
Journal:  Contemp Clin Trials       Date:  2007-02-27       Impact factor: 2.226

9.  Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment.

Authors:  Judith J Lok; Michael D Hughes
Journal:  Stat Med       Date:  2016-01-14       Impact factor: 2.373

10.  The Multicenter AIDS Cohort Study: retention after 9 1/2 years.

Authors:  J Dudley; S Jin; D Hoover; S Metz; R Thackeray; J Chmiel
Journal:  Am J Epidemiol       Date:  1995-08-01       Impact factor: 4.897

View more
  2 in total

1.  The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.

Authors:  Gaohong Dong; Lu Mao; Bo Huang; Margaret Gamalo-Siebers; Jiuzhou Wang; GuangLei Yu; David C Hoaglin
Journal:  J Biopharm Stat       Date:  2020-06-17       Impact factor: 1.051

2.  A causal framework for classical statistical estimands in failure-time settings with competing events.

Authors:  Jessica G Young; Mats J Stensrud; Eric J Tchetgen Tchetgen; Miguel A Hernán
Journal:  Stat Med       Date:  2020-01-27       Impact factor: 2.373

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.